OPCS coding (Office of Population, Censuses and Surveys Classification of Surgical Operations and Procedures) (4th revision)

Similar documents
APPENDIX ONE: ICD CODES

Surgical Workload, Outcome and Research Database: V1.1

Technical Guidance for Surgical Workload Audit and Research Database: Cholecystectomy V1.0

Setting The study setting was hospital. The economic analysis was carried out in California, USA.

Cancer in Estonia 2014

Cancer Association of South Africa (CANSA)

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

Information Services Division NHS National Services Scotland

S2 File. Clinical Classifications Software (CCS). The CCS is a

Information Services Division NHS National Services Scotland

155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary

Supplementary Online Content

CEA (CARCINOEMBRYONIC ANTIGEN)

Outcomes Report: Accountability Measures and Quality Improvements

National Cancer Patient Experience Survey 2016 Technical Documentation July 2017

Information Services Division NHS National Services Scotland

Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths

MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site

ANNUAL CANCER REGISTRY REPORT-2005

Epidemiology in Texas 2006 Annual Report. Cancer

Subtotal cholecystectomy for complicated acute cholecystitis: a multicenter prospective observational study

Hu J, Gonsahn MD, Nerenz DR. Socioeconomic status and readmissions: evidence from an urban teaching hospital. Health Aff (Millwood). 2014;33(5).

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence

SUPPLEMENTARY MATERIAL Risk of cancer in patients with thyroid disease and venous thromboembolism

OP-10: ABDOMEN CT USE OF CONTRAST MATERIAL

Technical Guidance for Surgical Workload Audit and Research Database: Anti Reflux Surgery V1.0

Comprehensive cancer cover

Cancer in New Mexico 2017

A Handbook of Statistical Analyses Using R. Brian S. Everitt and Torsten Hothorn

Appendix 9: Endoscopic Ultrasound in Gastroenterology

Appendix 5. EFSUMB Newsletter. Gastroenterological Ultrasound

Logistic regression. Department of Statistics, University of South Carolina. Stat 205: Elementary Statistics for the Biological and Life Sciences

Comprehensive cancer cover

Cancer in New Mexico 2014

Self-assessment test of prerequisite knowledge for Biostatistics III in R

3 Materials and Methods

Poisson regression. Dae-Jin Lee Basque Center for Applied Mathematics.

Cancer survival in Shanghai, China,

*

Empirical assessment of univariate and bivariate meta-analyses for comparing the accuracy of diagnostic tests

EFSUMB EUROPEAN FEDERATION OF SOCIETIES FOR ULTRASOUND IN MEDICINE AND BIOLOGY Building a European Ultrasound Community

ALL CANCER (EXCLUDING NMSC)

American Cancer Society Estimated Cancer Deaths by Sex and Age (years), 2013

CHAPTER 10 CANCER REPORT. Jeremy Chapman. and. Angela Webster

National level ICD 9-3 digit Nuts II european shortlist Croatia 1999/2000 From WHO ICD-10, 4 digit. 1999/2000 From WHO ICD-10, 4 digit

University of Bristol - Explore Bristol Research

Trends in Irish cancer incidence with predictions to 2020

2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill

Overview of 2009 Hong Kong Cancer Statistics

Technical appendix: The impact of integrated care teams on hospital use in North East Hampshire and Farnham

Selected tables standardised to Segi population

Cancer survival in Seoul, Republic of Korea,

0301 Anemia Others. Endocrine nutritional and metabolic disorders Others Vascular dementia and unspecified dementia

5.2 Main causes of death Brighton & Hove JSNA 2013

A Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files

John R. Marsh Cancer Center

Classification of Neoplasms

Prediction of Cancer Incidence and Mortality in Korea, 2018

Carcinoembryonic Antigen

From A to Z-Codes Matter

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Congenital dilatation of the common bile duct and pancreaticobiliary maljunction clinical implications

General Surgery Getting to the Core. Disclaimer

Unequal Impact: Māori and Non-Māori Cancer Statistics

Estimated Minnesota Cancer Prevalence, January 1, MCSS Epidemiology Report 04:2. April 2004

Globally Optimal Statistical Classification Models, I: Binary Class Variable, One Ordered Attribute

International Journal of Health Sciences and Research ISSN:

Diagnosis-specific morbidity - European shortlist

ALL CANCER (EXCLUDING NMSC)

Cancer in Utah: An Overview of Cancer Incidence and Mortality from

Prediction of Cancer Incidence and Mortality in Korea, 2013

Annual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care.

AJCC 7th Edition Handbook Errata as of 9/21/10

Scottish Clinical Coding Standards

Pancreas & Biliary System. Dr. Vohra & Dr. Jamila

Laparoscopic & Robotic Surgery in Pancreas Disease

Gastrointestinal Scoping Pack. July 2016

Florida Cancer Data System STAT File Documentation Version 2019

Suicides increased in 2014

Hazelinks - Cancer incidence analysis (First data extraction)

CODING PRIMARY SITE. Nadya Dimitrova

Cholangiocarcinoma (Bile Duct Cancer)

Laparoscopic cholecystectomyy

Checklist; Anus: Excisional Biopsy Anus: Excisional Biopsy 1/1/ Checklist; Anus: Resection Anus: Resection 1/1/2005

MALIGNANT NEOPLASMS OF THE BREAST MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS

Icd 9 code for small cell lung cancer

CANCER FACTS & FIGURES For African Americans

Prioritized ShortList MORBIDITY

Cancer in the Northern Territory :

Key Words. Cancer statistics Incidence Lifetime risk Multiple primaries Survival SEER

TABLE C-1 RESIDENT DEATHS, LIVE BIRTHS, FETAL, INFANT, NEONATAL, AND MATERNAL DEATHS: PENNSYLVANIA,

Endoscopic Retrograde Pancreatography and Laparoscopic Cholecystectomy. TEAM 1 Janix M. De Guzman, MD Presentor

Outcomes Report: Accountability Measures and Quality Improvements

Investigation of relative survival from colorectal cancer between NHS organisations

2016 Cancer Registry Annual Report

Diagnosing cancer in an emergency: Patterns of emergency presentation of cancer in Ireland

Cancer in Central and South America BOLIVIA

Cancer in Ireland : Annual Report of the National Cancer Registry

All Discovered Death Outcome Detail (Form 124/120)

Transcription:

Web appendix: Supplementary information OPCS coding (Office of Population, Censuses and Surveys Classification of Surgical Operations and Procedures) (4th revision) Procedure OPCS code/name Cholecystectomy J18.1 Total cholecystectomy and excision of surrounding tissue J18.2 Total cholecystectomy and exploration of common bile duct J18.3 Total cholecystectomy NEC J18.4 Partial cholecystectomy and exploration of common bile duct J18.5 Partial cholecystectomy NEC J18.8 Other specified excision of gall bladder J18.9 Unspecified excision of gall bladder Laparoscopic approach Y75.1 Laparoscopically assisted approach to abdominal cavity Y75.2 Laparoscopic approach to abdominal cavity NEC Y75.3 Robotic minimal access approach to abdominal cavity Y75.4 Hand assisted minimal access approach to abdominal cavity Y75.5 Laparoscopic ultrasonic approach to abdominal cavity Y75.8 Other specified minimal access to abdominal cavity Y75.9 Unspecified minimal access to abdominal cavity OPCS4.2 (until 142006) Y50.8 Other Specified Approach Through Abdominal Cavity Open conversion Y71.4* Failed minimal access approach converted to open Y71.8* Other specified * inconsistently applied in earlier years and not used in analysis Operative cholangiography J37.2 Operative cholangiography through cystic duct J37.3 Direct puncture operative cholangiography Includes: Operative cholangiography NEC ERCP J38.x Endoscopic incision of sphincter of Oddi J39.x Other therapeutic endoscopic operations on ampulla of Vater J40.x Endoscopic retrograde placement of prosthesis in bile duct J41.x Other therapeutic endoscopic retrograde operations on bile duct J42.x Therapeutic endoscopic retrograde operations on pancreatic duct J43.x Diagnostic endoscopic retrograde examination of bile duct and pancreatic duct J44.x Diagnostic endoscopic retrograde examination of bile duct J45.x Diagnostic endoscopic retrograde examination of pancreatic duct Bile duct exploration J18.2 Total cholecystectomy and exploration of common bile duct J18.4 Partial cholecystectomy and exploration of common bile duct In combination with cholecystectomy code: J31.x Open introduction of prosthesis into bile duct (ALL) J33.x Incision of bile duct (ALL) J35.x Incision of sphincter of Oddi using duodenal approach (ALL) 1

ICD coding of excluded patients Diagnosis name ICD10 code N Carcinoma in situ of other and unspecified digestive organs D015 1 Diffuse nonhodgkin's lymphoma C833 1 Leiomyoma of uterus D259 1 Lymphoid leukaemia C911 1 Malignant neoplasm of breast C504 6 Malignant neoplasm of bronchus and lung C349 5 Malignant neoplasm of cervix uteri C539 1 Malignant neoplasm of colon C189 11 Malignant neoplasm of gallbladder C23X 99 Malignant neoplasm of kidney, except renal pelvis C64X 5 Malignant neoplasm of liver and intrahepatic bile ducts C229 17 Malignant neoplasm of oesophagus C159 3 Malignant neoplasm of other and illdefined digestive organs C269 1 Malignant neoplasm of pancreas C250 38 Malignant neoplasm of rectosigmoid junction C19X 2 Malignant neoplasm of rectum C20X 2 Malignant neoplasm of small intestine C170 3 Malignant neoplasm of stomach C169 11 Malignant neoplasm without specification of site C80X 6 Maligt neoplasm of other and unspec parts biliary tract C249 7 Neoplasm of uncertain/unknown behaviour of endocrine glands D441 1 Neoplasm uncert or unkn behaviour oral cav and diges organs D377 6 Neuromuscular dysfunction of bladder NEC N318 1 Open wound of abdomen, lower back and pelvis S318 2 Other and unspecified types of nonhodgkin's lymphoma C851 8 Other malignant neoplasms of skin C444 2 Sec malignant neoplasm of respiratory and digestive organs C787 18 Secondary and unspecified malignant neoplasm of lymph nodes C772 1 Secondary malignant neoplasm of other sites C796 3 Injury of intraabdominal organs S3610 12 Total 275 2

Note on the exclusion of patients treated in private hospitals The patients in the dataset from private hospitals were exclusively from NHS waitinglist initiatives. We did not have access to data of the standard patients from these hospitals. These numbers therefore do not reflect total hospital volume and so we had no choice but to exclude them. Definition of categorical volume groups The definition of categorical volume groups was considered at length prior to starting the study. Firstly and most importantly, hospital volume is considered as a continuous variable in all models, i.e. mean annual hospital procedure counts are used without conversion to a threelevel categorical variable. In the mortality and length of stay models, there is a significant relationship between the continuous hospital volume variable and the outcome variable. Reoperation and readmission are nonlinear and the continuous hospital volume variable does not correlate particularly well when considered in a linear model. The continuous variable is difficult to report as it is not intuitive being in logunits. To provide an easily interpretable result (at the cost of throwing away some information), we report hospital volume as a categorical variable with threelevels (low, medium and high volume). We have used a method whereby the entire cohort is equally divided into three groups. While this does afford maximum statistical, our prime motivation for using this method was to avoid accusations of arbitrarily setting cutoff points to maximise volume group differences. In general, other methods require dataanalysis to be performed and cutoff points defined on the basis of that analysis. Choice of morbidity score Different models of comorbidity were explored all models were run with both Charlson and Elixhauser scores. The choice made almost no difference to model performance. The 2 loglikelihoods are presented below (the lower the value, the better the goodness of fit of the model). As can be seen in the table below, there is at most a 0.3% difference between Charlson and Elixhauser for all outcome variables. Charlson Elixhauser mortality 2612.4 2622.9 reoperation 18276 18271 readmission 32692 32658 length of stay 1178428 1178259 The table below shows how morbidity model choice does not significantly alter parameter estimates and standard errors for mortality. Given all this, we have used the simpler method (Charlson). Hosp vol* Charlson Elixhauser mortality Low 1.512 (1.1092.086) 1.487 (1.0912.050) Medium 1.487 (1.0912.050) 1.434 (1.0471.984) *compared with high volume group 3

Simulation procedure and R script. A simulation procedure has been used to model absolute risk differences for patients of varying baseline risk. Rather than present the mathematical basis of this (which can be found in the references) we have included what we hope is a lay explanation. Consider a hypothetical survey of adult height. An investigator randomly samples a population and determines a sample mean (a quantity of interest) for adult height. The greater the number in the sample, the closer the sample mean is to that of the population and the more information we have about the probability distribution of height in that population. Now consider a logistic regression model of mortality after cholecystectomy against a number of explanatory variables (say age, sex and deprivation score). In the normal manner, coefficients (β) are estimated for explanatory variables together with a standard error reflecting the uncertainty of that point estimate. By setting explanatory variables at a chosen level (e.g. age = 50, sex = female, SIMD = 4), the absolute probability of death (a quantity of interest) can be determined from the model function. In a manner akin to the population sampling example above, the simulation procedure involves taking random draws from the probability distributions underlying the model coefficients. This is repeated many times (we have used 1000 000) and these simulated parameter estimates used to generate 1000 0000 estimates of the quantity of interest, in this example the absolute probability of death. The mean (expected value) of these estimates can be presented, together with SE/95% CI for the simulated distribution. 27 R is an opensource statistical environment which can be downloaded here http://www.rproject.org/. Below is a script which generates sample data and demonstrates a simple example of an absolute risk difference analysis. #### Example using randomly generated variables #### ## Define variables ## #Randomly define two sets of hospitals with 10000 cases in total hosp.group<factor(rbinom(10000,1,0.5)) #Define mortality. 5% in hosp.group = 1, 3% in hosp.group = 0 mortality<ifelse(hosp.group==1,rbinom(sum(hosp.group==1),1,0.05),rbinom(sum(hosp.group==0),1, 0.03)) #Age: random normal distribution with mean 50 SD 20. age<rnorm(10000,50,20) #Morbidity score. Randomly assigned. simd<rbinom(10000,4,0.5) #Bring variables together in dataframe data<data.frame(mortality, age, hosp.group, simd) ##Use package Zelig to specify logit model (install in normal manner) #install.packages("zelig") library(zelig) z.mortality<zelig(mortality ~ age + hosp.group + simd, model="logit", data=data) summary(z.mortality) #What follows is a standard logit model #The absolute numbers will differ depending on the randomly generated variables Call: zelig(formula = mortality ~ age + hosp.group + simd, model = "logit", data = data) Deviance Residuals: Min 1Q Median 3Q Max 0.4176 0.3309 0.2896 0.2610 2.7035 4

Coefficients: Estimate Std. Error z value Pr(> z ) (Intercept) 3.74543 0.17770 21.077 < 2e16 *** age 0.00477 0.00243 1.963 0.0496 * hosp.group1 0.47142 0.09956 4.735 2.19e06 *** simd 0.08433 0.04853 1.737 0.0823. Signif. codes: 0 *** 0.001 ** 0.01 * 0.05. 0.1 1 (Dispersion parameter for binomial family taken to be 1) Null deviance: 3627.5 on 9999 degrees of freedom Residual deviance: 3597.8 on 9996 degrees of freedom AIC: 3605.8 Number of Fisher Scoring iterations: 6 #Model coefficients expressed as odds ratios exp(z.mortality$coefficients) > exp(z.mortality$coefficients) (Intercept) age hosp.group1 simd 0.02362553 1.00478153 1.60226195 1.08798506 #Want to find the absolute risk difference for mortality (first difference in expected values) between hospital groups, holding age and simd at mean #Set covariates at chosen level x.mortality_0 <setx(z.mortality, hosp.group=0) x.mortality_1 <setx(z.mortality, hosp.group=1) #Simulate quantity of interest s.mortality<sim(z.mortality, x=x.mortality_0, x1=x.mortality_1) summary(s.mortality) Model: logit Number of simulations: 1000 Values of X (Intercept) age hosp.group1 simd 1 1 50.02982 0 1.9867 Values of X1 (Intercept) age hosp.group1 simd 1 1 50.02982 1 1.9867 Expected Values: E(Y X) #expected values for hosp.group=1 mean sd 2.5% 97.5% 1 0.03448615 0.002514324 0.02981267 0.03978032 Predicted Values: Y X 0 1 1 0.978 0.022 First Differences in Expected Values: E(Y X1)E(Y X) #difference in mortality about 2% as would be expected given the variable definitions mean sd 2.5% 97.5% 1 0.01936902 0.004039653 0.01124012 0.02697273 Risk Ratios: P(Y=1 X1)/P(Y=1 X) mean sd 2.5% 97.5% 1 1.569786 0.1468423 1.299199 1.872838 5

Upper panel, total cholecystectomy count by volume group 19982007. Lower panel, proportion of cholecystectomies completed laparoscopically by admission type and hospital volume group. 6

Additional multivariable models Mortality (standard logit model) Reoperation (fixedeffects model) Readmission (fixedeffects model) Odds ratio (95% CI) p value Odds ratio (95% CI) p value Odds ratio (95% CI) p value Length of stay (generalised linear model)* Coefficient (logscale; 95% CI) p value Operation year 0.93 (0.890.97) 1.03 (1.011.04) 1.01 (1.001.02) 0.0720 0.039 (0.0420.037) Age, y <40 4054 5569 70 Gender Male Female Admission type Elective Nonelective Diagnosis Cholelithiasis Cholecystitis Acute pancreatitis Other 3.50 (1.329.32) 10.74 (4.3226.70) 38.86 (15.8595.28) 1.46 (1.151.87) 0.012 5.64 (4.267.47) 2.07 (1.522.83) 1.61 (0.823.15) 8.55 (6.3411.54) 0.92 (0.811.04) 1.20 (1.061.35) 1.53 (1.331.75) 0.002 1.34 (1.221.47) 0.166 0.175 0.003 2.60 (2.382.85) 0.84 (0.740.94) 1.30 (1.011.66) 1.31 (1.111.55) 0.92 (0.851.00) 0.92 (0.841.00) 1.09 (0.991.21) 1.22 (1.141.31) 0.002 0.041 0.002 0.046 0.038 0.070 1.69 (1.581.81) 1.00 (0.931.08) 1.06 (0.851.31) 1.27 (1.121.43) 0.165 (0.1470.183) 0.419 (0.4010.437) 0.964 (0.9420.987) 0.184 (0.1680.200) 0.098 0.613 0.762 (0.7450.778) 0.084 (0.0670.101) 0.156 (0.1020.210) 0.336 (0.3050.367) Deprivation 0.82 (0.750.91) 0.96 (1.041.17) 0.001 0.96 (0.940.98) 0.039 (0.0420.037) Morbidity 1.39 (1.261.54) 1.10 (1.1041.17) 0.001 1.27 (1.22 1.32) 0.144 (0.1320.155) Hospital volume High Medium Low 1.45 (1.062.00) 1.52 (1.112.08) 0.022 0.010 1.77 (1.591.97) 1.24 (1.101.39) 1.17 (1.091.26) 1.10 (1.021.19) 0.015 0.254 (0.2380.271)) 0.227 (0.2100.243) * Generalised linear model of length of stay following cholecystectomy. The LOS data were first fitted to different distributions with varying link functions using generalised linear modelling: linear (with identity or log link functions), gamma (with log link), Poisson (with log link) and negative binomial (with log link). Model performance was assessed using likelihood ratio tests and the Akaike information criterion. The gamma distribution with loglink function fitted the data best and was used in the final analysis. As errors in estimates can occur if backexponentiation is performed, the results are left on the logscale. 7

Subset analysis of outcomes after laparoscopic cholecystectomy, excluding primary open and open conversion procedures (N=43 407) Mortality (relogit model) Reoperation (mixed effects multilevel model) Readmission (mixed effects multilevel model) Odds ratio (95% CI) p value Odds ratio (95% CI) p value Odds ratio (95% CI) p value Length of stay (Cox proportional hazards) Hazard ratio for discharge (95% CI) p value Operation year 0.92 (0.841.00) 0.056 1.03 (1.011.05) 0.004 1.02 (1.011.03) 0.005 1.04 (1.031.04) Age, y <40 4054 5569 70 Gender Male Female Admission type Elective Nonelective Diagnosis Cholelithiasis Cholecystitis Acute pancreatitis Other 2.26 (0.7211.49) 6.51 (2,6032.02) 23.29 (9.63114.83) 2.03 (1.253.28) 0.229 0.002 4.28 (2.637.04) 1.30 (0.662.30) 7.49 (4.0013.25) 0.83 (0.710.97) 1.00 (0.861.16) 1.21 (1.001.46) 0.004 1.31 (1.151.50) 0.401 0.018 0.963 0.052 2.39 (2.092.72) 0.85 (0.721.01) 1.25 (0.891.74) 1.49 (1.151.94) 0.058 0.196 0.003 0.90 (0.821.00) 0.88 (0.800.97) 1.04 (0.911.18) 1.19 (1.091.30) 0.042 0.014 0.597 1.72 (1.581.87) 1.02 (0.921.13) 1.00 (0.771.30) 1.30 (1.091.56) 0.724 0.988 0.004 0.91 (0.890.94) 0.75 0.730.76) 0.50 (0.480.51) 0.93 (0.910.96) 0.48 (0.470.50) 0.94 (0.920.97) 0.91 (0.840.98) 0.94 (0.900.99) Deprivation 0.72 (0.580.86) 0.001 0.96 (0.921.00) 0.053 0.94 (0.910.96) 1.04 (1.041.05) Morbidity 1.31 (1.011.56) 0.016 1.14 (1.041.24) 0.004 1.30 (1.231.37) 0.89 (0.870.90) Hospital volume High Medium Low 2.14 (1.184.18) 1.88 (1.003.75) 0.018 0.060 1.94 (1.542.43) 1.28 (1.021.61) 0.036 1.23 (1.131.35) 1.14 (1.041.26) 0.008 0.72 (0.700.74) 0.79 (0.770.80) 0.013 0.027 8

Logistic regression models for probability of completing cholecystectomy using an open vs. laparoscopic approach, and of performing an operative cholangiogram Odds of cholecystectomy completed open vs. laparosopic (fixedeffects logit model) Odds of operative cholangiogram being performed (fixedeffects logit model) Odds ratio (95% CI) p value Odds ratio (95% CI) p value Operation year 1.09 (1.081.10) 0.94 (0.930.95) Age, y <40 4054 5569 70 Gender Male Female Admission type Elective Nonelective Diagnosis Cholelithiasis Cholecystitis Acute pancreatitis Other 1.20 (1.141.27) 1.57 (1.491.65) 2.31 (2.162.46) 1.44 (1.421.56) 1.56 (1.491.63) 1.49 (1.421.56) 0.72 (0.620.85) 2.95 (2.723.20) 1.04 (0.971.11) 1.15 (1.071.23) 1.19 (1.091.29) 1.07 (1.011.14) 0.285 0.022 1.65 (1.561.75) 0.56 (0.520.61) 2.30 (1.992.67) 0.74 (0.660.83) Deprivation 0.93 (0.920.94) 0.98 (0.960.99) 0.013 Morbidity 1.14 (1.101.17) 1.02 (0.981.06) 0.385 Hospital volume High Medium Low 1.72 (1.631.81) 2.86 (2.723.00) 0.27 (0.250.29) 0.50 (0.470.53) 9